Neurogene Inc. | SEC Filings

Filing Date	Form	Description	Filing Group	View
Nov 13, 2023	SEC STAFF LETTER	SEC Staff Letter: 14A-8		View HTML 9999999997-23-004660.pdf
Nov 08, 2023	S-4/A	Pre-effective amendment to an S-4 filing	Registration Statements	View HTML 0001193125-23-273390.pdf 0001193125-23-273390.rtf 0001193125-23-273390.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 08, 2023	CORRESP	CORRESP	Other	View HTML 0001193125-23-273399.pdf 0001193125-23-273399.rtf 0001193125-23-273399.xls
Nov 08, 2023	CORRESP	CORRESP	Other	View HTML 0001193125-23-273405.pdf 0001193125-23-273405.rtf 0001193125-23-273405.xls
Oct 18, 2023	S-4/A	Pre-effective amendment to an S-4 filing	Registration Statements	View HTML 0001193125-23-258478.pdf 0001193125-23-258478.rtf 0001193125-23-258478.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 18, 2023	CORRESP	CORRESP	Other	View HTML 0001193125-23-258483.pdf 0001193125-23-258483.rtf 0001193125-23-258483.xls
Oct 10, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001209191-23-052526.pdf 0001209191-23-052526.rtf 0001209191-23-052526.xls
Oct 10, 2023	SC 13D/A	An amendment to a SC 13D filing	Other	View HTML 0001104659-23-108324.pdf 0001104659-23-108324.rtf 0001104659-23-108324.xls
Oct 10, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-011090.pdf 0000000000-23-011090.rtf
Oct 10, 2023	SEC STAFF LETTER	SEC Staff Letter: 14A-8		View HTML 9999999997-23-004726.pdf

Data provided by Kaleidoscope.

Form 8937

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 in order to report organizational actions, including nontaxable distributions that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only. Please consult your personal tax advisor for assistance as to how this information will impact your specific tax situation.